Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
TR
Trulieve Cannabis Corp.
TRLV
Mkt Cap
$1.93B
Volume
853.34K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
TR
TRLV
TR
Trulieve Cannabis Corp.
TRLV
News
·
Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve Cannabis
Mkt Cap
$1.93B
Volume
853.34K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Insider
Filings
Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve Cannabis
The Medical Products industry faces moderate growth prospects with resilient healthcare demand offset by tariff pressures and manufacturing costs. ICU Medical shows strong momentum in infusion systems with improving earnings, Neogen benefits from commercial execution improvements in food and animal safety, while Trulieve Cannabis expects growth acceleration from new markets like Georgia and Texas despite Florida seasonal softness.
Zacks Investment Research · Oct 12, 2026
2 Cannabis Stocks That Are Quietly Trouncing the Market in 2026
Trulieve Cannabis and Cronos Group have both gained approximately 27% in 2026, outpacing the S&P 500's 12% gain. Trulieve, now listed on the NYSE, generated $74 million in free cash flow in H1 2026 with a 60% gross margin. Cronos delivered 58% year-over-year revenue growth to $53 million in Q2 with expanding margins and $827 million in cash, while also returning capital to shareholders through share buybacks.
The Motley Fool · Sep 22, 2026
The First U.S. Marijuana Stock Is Now Trading on the NYSE. Here's What That Means for Every Cannabis Investor.
Trulieve Cannabis became the first U.S. cannabis operator to list on the NYSE after the federal government reclassified medical marijuana to Schedule III. This milestone could open doors for institutional investors and improve market access for the cannabis industry, though significant challenges including debt, market saturation, and regulatory uncertainty remain.
The Motley Fool · Jun 14, 2026
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
TR
TRLV
Trulieve Cannabis Corp.
Buy
Sell
Market
Limit
Soon
TRLV
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any TRLV yet.
Related Tickers
Earnings